Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

470.418
+12.2352.67%
Number of Gainers:39
Number of Losers:9
Number of Flat:7
PE:- -
High:475.126
Open:458.152
Low:457.597
Close:458.183
Volume:617.35M
Turnover:17.78B
Market Cap:2.86T
Float Cap:2.11T

Loading ...

Modern Dental Reports Annual Profit Surge of 46.32% to HK$597 Million

Stock News
·
Mar 26

XTEP Projects Over 10% Net Profit Growth for 2025 Driven by Product Strength and Enhanced Running Shoe Portfolio

Deep News
·
Mar 26

Morgan Stanley's Meituan Performance Review: No Surprises, Core Focus Remains on Market Share and Margin Recovery

Deep News
·
Mar 26

Jinxin Fertility Group FY Net Income Attributable RMB -976.1 Million

THOMSON REUTERS
·
Mar 26

Modern Dental Group adopts share award scheme; plan cap set at 10% of issued shares

Reuters
·
Mar 26

Modern Dental Group FY Revenue HKD 3,736.5 Million

THOMSON REUTERS
·
Mar 26

Modern Dental Group Ltd - Final Dividend of HK15.0 Cents per Ordinary Share

THOMSON REUTERS
·
Mar 26

Modern Dental - Net Profit for Year HK$601.2 Mln

THOMSON REUTERS
·
Mar 26

Blue Moon Group FY2025 final dividend is proposed at HKD 0.1 per share; shareholders vote May 22, 2026

Reuters
·
Mar 26

Bairong Cloud-W Proposes Rebranding to Bairong AI Inc.

Stock News
·
Mar 26

Meituan Projects Enhanced Per-Order Loss Reduction in Food Delivery for Q1 Compared to Q4

Stock News
·
Mar 26

KeyMed Biosciences Announces 2025 Annual Results and Business Updates

THOMSON REUTERS
·
Mar 26

Blue Moon Group FY2025 loss narrowed 56.1% to HK$329 million; revenue fell 1.7% to HK$8.4 billion

Reuters
·
Mar 26

Blue Moon Group Holdings FY Net Income Attributable HKD -328.9 Million

THOMSON REUTERS
·
Mar 26

Blue Moon Group - Final Dividend of HK10.0 Cents per Share

THOMSON REUTERS
·
Mar 26

Meituan CEO Outlines AI Strategy: Beyond Understanding to Efficient Execution

Stock News
·
Mar 26

KEYMED BIO-B Reports Widened Annual Loss Amid Revenue Growth

Stock News
·
Mar 26

KeyMed Biosciences FY Revenue RMB 716.3 Million

THOMSON REUTERS
·
Mar 26

KeyMed Biosciences FY Net Income Attributable RMB -522.6 Million

THOMSON REUTERS
·
Mar 26

Keymed Biosciences FY2025; Kangyueda sales climb to CNY 315 million; revenue rises to CNY 716 million

Reuters
·
Mar 26